	Correction: Global trend analysis and risk evolution of asbestos-related ovarian cancer: a population-based study and future prediction (1990-2021). Front Public Health Li X, Li J, Shan D, Zhou M, Li M, Li Y, Xia M, Deng H. PMID: 41705052 [PubMed - in process]
	Validation of Chinese medicine syndrome differentiation in early breast cancer: a multicenter prospective clinical study. Front Oncol Luo W, Dai Y, Wu J, Xue X, Liu L, Bian W, Xie X, Lyu G, Hong R, Qiu C, Lin X, Xu R, Guo Q, Chen Q. PMID: 41704617 [PubMed]
	Evaluation of Ginsenosides and Their Derivatives From Panax ginseng as Aromatase Inhibitors for Breast Cancer Treatment-An in silico study. Biomed Res Int Madhan JG, Sekaran S, Akshaya RN, Venkatesan K, Kirupanandasamy K, Vijayakumar K, Jenifer N, Paul BC. PMID: 41704531 [PubMed - indexed for MEDLINE]
	Case Report: Primary cutaneous apocrine carcinoma mimicking breast carcinoma - a rare diagnostic challenge. Front Oncol Kameh Khosh M, Hirsch T, Schulze HJ, Kuhnen C, Wellenbrock S. PMID: 41704473 [PubMed]
	Evaluation of trimetazidine in alleviating paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial. Front Pharmacol Iqbal AN, Mady FM, Sadek EM, Abdullah NM, Abdel-Azeez AM, Shorog E, Wahsh EA. PMID: 41704280 [PubMed]
	The effect of two remote exercise programs on cardiorespiratory fitness, cardiac function, and vascular health in patients with breast cancer. Physiol Rep Weeldreyer NR, Ellison CC, Mabalot MB, Helms CE, Nealy ZB, Leicht ZS, Abbate A, Brenin CM, Dillon PM, Millard T, Krukowski RA, Zoellner JM, Angadi SS. PMID: 41704018 [PubMed - indexed for MEDLINE]
	CDK4/6 inhibitors combined with fulvestrant for the treatment of HR+/HER2-advanced or metastatic breast cancer: a Bayesian network meta-analysis. BMC Cancer Deng Y, Huang W, Zeng T, Gao Y. PMID: 41703509 [PubMed - as supplied by publisher]
	Fluoxetine suppresses triple-negative breast cancer progression by inducing apoptosis, inhibiting Src-mediated invasiveness, and enhancing anti-tumor immunity. Mol Med Wu HJ, Weng YS, Liu YC, Wei YT, Li PY, Lee PY, Hsu FT. PMID: 41703443 [PubMed - as supplied by publisher]
	RapidArc Dynamic (RAD) multi-mechanical axis optimization achieves enhanced OAR sparing in cervical cancer: A dosimetric comparison study. J Appl Clin Med Phys Meng X, Wang Z, Zhang Y, Wang X, Wang X, Zhu W, Chen F, Zhang Z, Xu F, Wu Z, Yang B, Qiu J. PMID: 41703358 [PubMed - indexed for MEDLINE]
	A Novel Approach to Ovarian Cancer Diagnosis via CT Imaging: GPT-4o-Driven Automated Feature Recognition and Validation in Clinical Settings. Ann Surg Oncol Zhang S, Hou Q, Ding M, Zhu Y, Dai G, Lu Z, Liu Z, Chen B, Li X, Liu J, Deng K, Song J, Zhou X. PMID: 41703208 [PubMed - as supplied by publisher]
	Estimating treatment effects on duration with disease: a principal stratification framework. Lifetime Data Anal Parner ET. PMID: 41703169 [PubMed - indexed for MEDLINE]
	Altered trace and toxic element profiles in breast tissue: a case-control study of cancer risk. Sci Rep Farrokhzadeh H, Tarrahi MJ, Baradaran A, Keyhanian K, Sohrabi K, Mohammadi F, Gholipour S, Pourzamani H. PMID: 41703096 [PubMed - as supplied by publisher]
	Development and validation of a novel nomogram predicting axillary lymph node metastasis among breast cancer patients in Egypt. Sci Rep Ismail HM, Arafa MA, Elsaid AAA, Tahoun MM. PMID: 41703012 [PubMed - as supplied by publisher]
	Different BI-RADS breast cancer diagnosis using MobileNetV1 and vision transformer based on explainable artificial intelligence (XAI). Sci Rep Abdelsabour I, Elgarayhi A, Sallah M, Elmogy M. PMID: 41702964 [PubMed - as supplied by publisher]
	Phase II trial of anlotinib-chemotherapy combination in pretreated HER2-negative metastatic breast cancer: therapeutic efficacy and proteomic biomarker profiling. NPJ Breast Cancer Xu T, Gu Q, Li S, Zhang L, Yuan Y. PMID: 41702931 [PubMed - as supplied by publisher]
	Vitamin D supplementation before in vitro fertilisation in women with polycystic ovary syndrome: multicentre, double blind, placebo controlled, randomised clinical trial. BMJ Hu KL, Liao T, Wu Q, Ma X, Cao Y, Tan J, Tian L, Wang J, Yin J, Liu Y, Zhao J, Zhao S, Li M, Cai L, Liu FT, Gan K, Xu Y, Wang Y, Cai J, Zheng B, Ma Y, Ma Q, Zheng J, Pu X, Zhang H, Hao C, Xie Q, Zhang C, Jiang L, Zhang S, Yan L, Meng Q, Li W, Mol BW, Li R, Wang R, Zhang D, VitD-PCOS trial group. PMID: 41702641 [PubMed - indexed for MEDLINE]
	Review on 11-Oxygenated steroids in hormone-related diseases: polycystic ovary syndrome, endometrial cancer, prostate cancer. J Steroid Biochem Mol Biol Jin X, Werner HMJ, Romano A. PMID: 41702503 [PubMed - as supplied by publisher]
	Circulating tumor DNA in breast cancer: From technological foundation to clinical implementation. Cancer Treat Rev Lin X, Liu B, Wu J, Shi L, Zhang Y, Yang Q, Tang H, Xu S, Gao Y, Cui J, Zhang Y. PMID: 41702297 [PubMed - as supplied by publisher]
	Enhancing breast cancer diagnostics: Shape-aware angular feature learning for precision in breast cancer classification. Comput Biol Chem Saudagar AKJ, Kumar A, Kumar A. PMID: 41702230 [PubMed - as supplied by publisher]
	Advances in Immunotherapy for Breast Cancer. Oncology (Williston Park) Poland S, de Oliveira Andrade Md M, Nanda R. PMID: 41701864 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 324588

Page 1 of 16230



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy